Kayla Parker

414 total citations
9 papers, 327 citations indexed

About

Kayla Parker is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kayla Parker has authored 9 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kayla Parker's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Diabetes Management and Research (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Kayla Parker is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Diabetes Management and Research (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Kayla Parker collaborates with scholars based in United States and Canada. Kayla Parker's co-authors include J D England, David E. Goldstein, R. Hess, Larry A. Tucker, Randie R. Little, John F. Simonds, Hsiao-Mei Wiedmeyer, Robi D. Mitra, Richard C. Whiting and Richard L. Eddy and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Clinical Chemistry.

In The Last Decade

Kayla Parker

9 papers receiving 291 citations

Peers

Kayla Parker
Suman Patel United States
Rudo F. Mapanga South Africa
G. S. Sundaram United States
Teresa H. Liao United States
Jacob B. Levine United States
H. Grassos Greece
Kayla Parker
Citations per year, relative to Kayla Parker Kayla Parker (= 1×) peers Eleftheria Papachristoforou

Countries citing papers authored by Kayla Parker

Since Specialization
Citations

This map shows the geographic impact of Kayla Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayla Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayla Parker more than expected).

Fields of papers citing papers by Kayla Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayla Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayla Parker. The network helps show where Kayla Parker may publish in the future.

Co-authorship network of co-authors of Kayla Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Kayla Parker. A scholar is included among the top collaborators of Kayla Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayla Parker. Kayla Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tucker, Larry A. & Kayla Parker. (2022). 10-Year Weight Gain in 13,802 US Adults: The Role of Age, Sex, and Race. Journal of Obesity. 2022. 1–10. 26 indexed citations
2.
Parker, Kayla, et al.. (2021). The clinical effect of glucose meter selection upon the detection of neonatal hypoglycemia. Paediatrics & Child Health. 27(1). 12–14. 1 indexed citations
3.
Parker, Kayla, et al.. (2020). 12 Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency: literature review and results transferability. Paediatrics & Child Health. 25(Supplement_2). e4–e5. 1 indexed citations
4.
Inman, Mark D., et al.. (2019). A Simulation Study to Assess the Effect of Analytic Error on Neonatal Glucose Measurements Using the Canadian Pediatric Society Position Statement Action Thresholds. Journal of Diabetes Science and Technology. 14(3). 519–525. 5 indexed citations
5.
Parker, Kayla, et al.. (2015). Clinical Inquiry: Do statins increase the risk of developing diabetes?. PubMed. 64(4). 245–6. 1 indexed citations
6.
Goldstein, David E., Kayla Parker, J D England, et al.. (1982). Clinical Application of Glycosylated Hemoglobin Measurements. Diabetes. 31(Supplement_3). 70–78. 121 indexed citations
7.
Parker, Kayla, et al.. (1981). Improved colorimetric assay for glycosylated hemoglobin.. Clinical Chemistry. 27(5). 669–672. 153 indexed citations
8.
Whiting, Richard C., et al.. (1978). Enzyme immunoassay and gas--liquid chromatography compared for determination of lidocaine in serum.. Clinical Chemistry. 24(11). 2020–2022. 15 indexed citations
9.
Parker, Kayla & Richard L. Eddy. (1976). GROWTH HORMONE REFRACTORY INTERVAL TO LEVODOPA STIMULATION. The Journal of Clinical Endocrinology & Metabolism. 42(6). 1188–1191. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026